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Wound healing is a complex process involving a number of processes. Fetal regeneration has been shown to have a number of
diﬀerences compared to scar-forming healing. This review discusses the number of diﬀerences identiﬁed in fetal regeneration.
Understanding these diﬀerences may result in new therapeutic targets which may reduce or even prevent scarring in adult healing.
1.Introduction
Since the 1970s it has been well established that early human
fetuses can heal cutaneous wounds without the formation of
scar tissue [1]. This regeneration appears organ speciﬁc, as
in early fetuses which heal cutaneous wounds with perfect
r e g e n e r a t i o no t h e ro r g a n ss u c ha st h eg u th e a lw i t ht h e
formation of scar tissue. Studies on the marsupial embryo,
Monodelphis domestica, have shown that fetal regeneration is
not due to the moist, sterile environment of the uterus [2].
Further, this regenerative phenotype is cell speciﬁc with fetal
skin transplanted subcutaneously onto adults continuing to
show a regenerative phenotype [3] whereas skin from the
adult transplanted onto the fetus demonstrate an adult-like
scarring phenotype [4].
Wound healing is an inherent response resulting in
restoration of tissue integrity. It is a complex process involv-
ing cell migration, proliferation, diﬀerentiation, apoptosis,
and the synthesis and remodelling of the extra cellular
matrix (ECM). A number of factors are involved in the
various stages of tissue repair including cell-cell interactions,
cell-matrix interactions, a number of diﬀerent cell types,
and a large number of growth factors and cytokines. The
regenerative phenotype of the fetus has shown a diﬀerence
in a number of processes involved in wound healing, which
may be manipulated to reduce or even prevent scarring.
2. Inﬂammation
Fetal wound healing compared to adult wound healing has
been shown to have a diﬀerent and reduced inﬂammatory
response [5, 6]. The levels of immune cells are reduced
which include macrophages, which are also less activated,
and, in addition, the presence of inﬂammatory cells is short
lived in fetal wound healing compared to the adult [5–7].
The reduced number of inﬂammatory cells also means
lower expression levels of some growth factors and cytokines
and for a shorter duration of time [8, 9]. However, studies
have shown that fetuses which are artiﬁcially stimulated
to produce an inﬂammatory response show an adult-like
response with scar formation [10, 11]. It appears that no
single immune cell is essential for wound healing [12–14]
with PU.1 knockout mice, which lack both macrophages and
neutrophils, showing improved rates of reepithelisation and
reduced scarring compared to their wild-type equivalents
[15].
The proinﬂammatory cytokines interleukin-6 (IL-6) and
interleukin-8 (IL-8) have been found to be decreased during
scarless fetal repair even when fetal ﬁbroblasts are stimulated
with platelet-derived growth factor (PDGF) [16, 17]. IL-
10 is known to be a major regulator in suppressing the
inﬂammatory response, including IL-6 and IL-8, and IL-
10 also inhibits the migration of inﬂammatory cells to sites
of injury [18–22]. Knockout animals for IL-10 demonstrate2 ISRN Dermatology
scar formation in fetal wounds which would have healed
without a scar [23] while over expression of IL-10 in adult
wounds, using genetic manipulation, decreased the inﬂam-
matory response, decreased abnormal collagen deposition,
a n dr e s t o r e dn o r m a la r c h i t e c t u r e[ 24].
Cyclooxygenase-2 (COX-2), part of the arachidonic acid
cascade, is upregulated in response to an inﬂammatory
response such as an injury. COX-2 functions by producing
prostaglandins which control many aspects of inﬂammation.
A murine model of scarless healing demonstrated low levels
of COX-2 and prostaglandin-2 (PGE2), whereas the addition
of exogenous PGE2 induced scar formation in a fetal model
of wound healing [25]. Blocking the COX-2 enzyme in
adult wounds results in a fetal-like phenotype with reduced
scarring [26]. However, both fetal and adult ﬁbroblasts
show expression of the PGE2 receptors [27]. PGE2 inhibited
ﬁbroblast migration, in both the fetus and adult, through
the EP2/EP4-cAMP protein kinase A pathway, though fetal
ﬁbroblasts appeared refractory requiring a higher concen-
tration to achieve the same eﬀect. The inhibition of adult
ﬁbroblast migration by PGE2 correlated with the disruption
of the actin cytoskeleton, and PGE2 also inhibited the
contraction of adult derived ﬁbroblast populated collagen
lattices.PGE2however,didnotdisrupttheactincytoskeleton
in fetal-derived ﬁbroblasts and further did not prevent
fetal ﬁbroblast populated collagen lattices contraction [27],
possibly because fetal ﬁbroblasts are thought to have a more
migratory phenotype [28].
3.ExtraC ell ularM atrix(ECM)
The ECM is known to play an important role in wound
healing as it can play a part in regulating growth factors and
cytokines and alter cell behaviour [29]. Fetal wounds have
been shown to have increased levels of glycosaminoglycans
such as hyaluronic acid (HA) and chondroitin sulfate,
which are long unbranched polysaccharides comprising of
repeating disaccharides found on the cell surface or in the
ECM. HA is found at higher levels and for a longer duration
in fetal wounds compared to adult wounds [30, 31]. This
increased expression is possibly due to the reduced activity
of hyaluronidase in the fetus [32] while fetal ﬁbroblasts also
express higher levels of the hyaluronic acid receptor (CD44)
compared to adult ﬁbroblasts [33]. Exogenous addition of
HA reduces the formation of scar tissue in adults [34, 35]
while reducing HA expression results in a phenotype more
akintoadulthealing[36].IncreasedlevelsofHAasidentiﬁed
in the fetus promotes both the proliferation and migration
of a number of cell types [37]; HA-rich matrices can bind
growth factors and cytokines which can result in temporal
and spatial diﬀerences of these factors.
Glycoproteins, such as ﬁbronectin, laminin, and tenascin
C, bind integrins, collagen, and proteoglycans and are inte-
gral components of the ECM playing a role in cell adherence
[38]. Fibronectin is involved in the migration of a number
of cells involved in wound healing including ﬁbroblasts,
keratinocytes, and endothelial cells. The ﬁbronectin family
consists of numerous splice variants in humans with a
number of variants being involved in both fetal development
and wound healing [39–41]. Fibronectin which is part of
the provisional matrix, shows similar temporal and spatial
expression in both fetal and adult sheep and mice [42, 43]
while another animal model (rabbit) suggests that fetal
wounds show an earlier expression of ﬁbronectin [44].
Tenascin C has shown earlier deposition in fetal wounds
which may be associated with the rapid reepithelisation seen
in fetal wounds [42, 43]. The wounded fetal human skin has
shown increased expression of integrin subunits α2, α3, α6,
and β4, (laminin and collagen receptors) and neoexpression
of α5, αV, and β6 (ﬁbronectin and tenascin C receptors), and
this may further explain the fetuses’ ability to reepithelise
wounds rapidly with a reduced presence of inﬂammatory
cells [45].
The proteoglycans decorin and ﬁbromodulin which are
known to regulate collagen ﬁbrillogenesis, growth factor
activity, and cellular proliferation have shown variation in
fetal wound healing. Decorin showed reduced expression in
fetal ﬁbroblasts and fetal skin compared to adult ﬁbroblasts
and skin [46]. While decorin was upregulated during adult
wound healing, it has also been shown that reduced or
delayed expression of decorin is associated with pathological
scarring in a number of adult models [47, 48]. Fibromod-
ulin, a further proteoglycan, showed an increase protein
expression in scarless wounds compared to scarring [49]a n d
similarly to decorin [50] is believed to alter the biological
activity of TGF-β.
Fetal and adult wounds show a number of diﬀerences in
collagen synthesis; these diﬀerences include speed of depo-
sition, variations in collagen ratios and quantity of collagen
itself [51–53]. Studies suggest that fetal ﬁbroblasts not only
show increased collagen III expression, but the new collagen
is deposited in a ﬁne reticular or basket weave pattern similar
to uninjured skin [54, 55]. However uninjured fetal skin
does show increased collagen III compared to collagen type I
[51–53]. Others have suggested that the collagen deposited
by fetuses is less mature with less cross-linking reducing
rigidity but not aﬀecting tensile strength [52]. This reduced
collagen cross-linking may be due to a lower expression of
lysyl oxidase, which is known to play a role in both collagen
cross-linking and inﬂuences collagen architecture [56]. Chin
et al. [57] also showed that fetal ﬁbroblasts show increased
expression of the collagen receptor DDR1 thought to be
important for both collagen expression and organization.
Though fetuses may show increased collagen production
they do not exhibit excessive collagen deposition, and this
may be through rapid turnover of the ECM components.
Fetal wounds show increased levels of the urokinase plas-
minogen activator and matrix metalloproteinases (MMPs)
while their inhibitors (PAI-1 and TIMPs) are reduced during
fetal wound healing [58–60]. Higher levels of MMPs result
in matrix degradation compared to matrix deposition. Dang
et al. [60] showed that scarless fetal healing expresses MMP-
1, MMP-9, and MMP-14 mRNA quicker and at higher levels
than ﬁbrotic fetal wounds. While MMP-2 and TIMP1 and
TIMP 3 expression are not altered during scarless healing,
whereas ﬁbrotic wounds show decreased levels of MMP2 but
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4. Myoﬁbroblasts and Contraction
Fetal studies have indicated that, unlike adult wound closure,
fetal wounds close through an actin cable which acts like a
purse string [61]. This cable assembles within minutes of
an injury and requires a GTPase, Rho, to reepithelise fetal
wounds [62]. Studies have shown that this cable may contain
myosin which acts in a zipper-like manner to close incisional
wounds in fetal skin [62], and paxillin mRNA expression
was upregulated and colocalised with actin in the fetus but
n o ti nt h ea d u l t[ 63]. Adult wound closure involves active
movements of connective tissue and epidermis. The adult
woundcontractstobringthetwosidesofthewoundedgesin
close proximity to allow the epidermis to migrate and cover
the exposed connective tissue [64].
Granulation tissue is thought to play a considerable
part in wound contraction in adult wound healing. Migrat-
ing adult ﬁbroblasts are capable of generating some ten-
sile strength to start contraction, and the myoﬁbroblast
(diﬀerentiated ﬁbroblast expressing alpha smooth muscle
actin) is the main cell responsible for wound contraction.
Diﬀerentiation of ﬁbroblasts to myoﬁbroblasts requires a
combination of growth factors, mechanical cues, and the
presence of the EDA variant of ﬁbronectin. The presence of
myoﬁbroblasts in fetal wounds remains controversial with
a murine model showing no alpha smooth muscle actin
expression (except associated with blood vessels [65]), which
was further replicated in a fetal sheep model [66]. However,
Cass et al. [67] did detect myoﬁbroblasts in fetal wound
healing but at earlier time points than in postnatal (scarring)
wound healing. Furthermore, others in an in vitro study
haveshownthathumanfetalﬁbroblastscandiﬀerentiateinto
myoﬁbroblasts when stimulated with exogenous TGF-β1b u t
again at earlier time points than postnatal ﬁbroblasts [68].
5. GrowthFactors
Growth factors and their receptors play a vital role in
wound healing with a number of aberrations associated with
abnormal wound healing such as pathological scarring. A
number of growth factors have shown diﬀerent expression in
fetal or scarless wound healing compared to adult or scarring
wound healing (Table 1).
The TGF-β family is multifunctional and is believed to
be important in both tissue repair and scarring. The three
isoforms of TGF-β are synthesized as latent precursors which
require activation before they can exert their biological
activity through binding to their heteromeric receptor
complexes. Fetal wound healing has shown a rapid induction
of TGF-β1 mRNA in fetal repair but at lower levels and
with a more rapid clearance from the wound site compared
to adult wounds [8, 69, 70]. Interestingly TGF-β2 levels,
also considered to be proﬁbrotic, was found to be lower in
adult-like repair compared to fetal repair [69]. The third
isoform,TGF-β3,isexpressedinadultanimalwoundhealing
[69, 71], though its expression is delayed [69], and with
lower levels [69] compared to fetal wounds and in in vitro
studies [68]. Studies have shown that blocking TGF-β1a n d
TGF-β2 may reduce scar tissue formation [72, 73]. Whereas,
the addition of exogenous TGF-β3 has in some animal
models shown improved scar formation [74]. Further, early
human clinical studies showed that exogenous TGF-β3i f
administered prior to the injury could reduce scarring [75].
However, other studies using a diﬀerent animal model have
shown that TGF-β3h a dn oe ﬀect in reducing scar tissue
formation [76]. There have been three TGF-β receptors
identiﬁed (TβRI, TβRII, and TβRIII), and variations in the
TGF-β receptor expressions have been identiﬁed in fetal
wound healing [8, 77].
Epidermal growth factor (EGF) is known to be involved
in wound healing and is thought to be mitogenic for a
number of cell types including ﬁbroblasts and keratinocytes.
EGF mRNA showed decreased levels with increasing ges-
tational age (scarring) [78]. Surprisingly, the proﬁbrotic
platelet-derived growth factor (PDGF) mRNA has also been
shown to be elevated in fetal skin compared to adult skin
[78] though similar to TGF-β it appears to have quicker
clearance in fetal wound healing [42]. However, fetal wounds
when treated with exogenous growth factors such as PDGF
showed a ﬁbrotic response, with increased inﬂammation,
ﬁbroblast recruitment and collagen deposition indicating
that fetal wound can respond in an adult manner in
response to exogenous PDGF [79]. The ﬁbroblast growth
factors (FGF) stimulate proliferation and regulate migration
and diﬀerentiation in a number of target cells [80]. FGF
isoforms are regulated in a complex manner during fetal skin
development, and though most do not change expression
in scarless healing, both FGF7 and FGF10 were found to
be downregulated [60]. The FGF receptor 2 (FGFR2) was
down regulated in wound healing, in both scar-forming
and scarless healing, but the downregulation was earlier
and more sustained in scarless healing [60]. While bFGF
(otherwise known as FGF2) and the FGF receptor-1 (ﬂg)
expressions were found to be higher in fetal skin than later
gestational skin [81].
The role that angiogenesis and in particular VEGF has in
scar formation remains unclear. Scarless fetal repair has not
only shown reduced angiogenesis in fetal wounds [82], but
growth factors associated with angiogenesis show reduced
or no expression [25, 70, 79]. Wilgus et al. showed in
a murine model that scarless fetal repair heals without
either increased VEGF or vascularity [9]. However, other
studies have suggested an increase in VEGF mRNA [83]. The
variation of the results may be due to the wound model
itself, that is, incisional versus excisional, diﬀerent time and
methods used and variations in animal model.
Insulin-like growth factors (IGF) are known proﬁbrotic
mitogens known to play a role in wound healing and fetal
development. Treating wounds with exogenous IGF-I has
been shown to accelerate wound healing through increased
collagen synthesis and its mitogenic eﬀect on keratinocytes
andﬁbroblasts[84,85].IGF-1hasbeenimplicatedinﬁbrotic
conditions including pathological scars possibly due to the
increase in collagen synthesis [86, 87]. However, human fetal
ﬁbroblasts showed a lower mitogenic response to IGF-I and
with a lower level of collagen synthesis compared to adult
ﬁbroblasts [88].4 ISRN Dermatology
Table 1: Diﬀerences identiﬁed in fetal wound healing compared to adult wound healing.
Growth factor Role in wound healing Adult wound healing Fetal wound healing
EGF Reepithelisation. Stimulate ﬁbroblasts to
secrete collagen
Decreased levels mRNA with
increasing gestational age [78]
VEGF Angiogenesis Remains unclear [9, 82]
PDGF Fibroplasia. Attract ﬁbroblast to wound
area.
Elevated levels but quicker
clearance from wounds [77].
Exogenous addition causes
ﬁbrosis [79]
FGF
Matrix deposition, reepithelisation,
angiogenesis, endothelial, keratinocyte,
and ﬁbroblast migration
FGF7 and 10 downregulated [60]
FGF2 increased expression [81]
TGF-β1
Neutrophil inﬁltration, macrophage
inﬁltration, ﬁbroplasia, matrix
deposition, scarring/ﬁbrosis angiogenesis
Increased levels, long intracellular
signalling. Causes increase in own
gene expression
Low levels with increased
clearance [8, 70, 71].
No increase in own gene
expression [101]
TGF-β2
Neutrophil inﬁltration, macrophage
inﬁltration, ﬁbroplasia, matrix
deposition, scarring/ﬁbrosis angiogenesis
High levels mRNA but not
protein [69]
TGF-β3 As above but possibly antiscarring Delayed expression Increased levels and quicker and
prolonged expression [69, 71]
IGF-I Matrix deposition, scarring,
re-epithelisation
Higher proliferation increased
collagen synthesis
Lower proliferation and collagen
synthesis [88]
6.CellSignalling,Transcription,and
GeneExpression
Fetal wound healing and fetal derived cells have indicated
that there may be diﬀerences in intracellular signalling
following the binding of the ligand (growth factor) to its
receptor. Martin et al. [70] demonstrated that TGF-β1i s
rapidly cleared from fetal scarless wounds. While others
have shown that the phosphorylation of receptors and some
intracellularsignallingproteinsdiﬀerbetweenfetalandadult
ﬁbroblasts [68, 88, 89]. The TGF-β1 signalling pathway has
been shown to be short lived in human fetal ﬁbroblasts
after stimulation with exogenous TGF-β1[ 68], while others
found no diﬀerence [90, 91]. Variation in results between the
studies may be explained through diﬀerent species (human
and mouse) and diﬀerent intracellular proteins studied
(Smad 2 or Smad 3 or Smad 2/3).
Wound healing requires the expression of a number of
genes which are regulated by a number of transcription
factors such as activator protein 1 (AP1) and the Hox genes.
The AP-1 transcription factor is a heterodimeric protein
composed of Fos, and Jun and activating transcription
factor protein family members. AP-1 induction has been
demonstrated in fetal mouse skin, while c-Fos protein was
demonstrated to be upregulated in the epidermis after
wounding [62, 92]. The increase in AP-1 and c-Fos is linked
to Rho, a GTPase, which is linked to the formation of
the actin cable in fetal wound closure. Others, have also
shown that AP-1 transcription factors were induced after
wounding in both scarless and scarring wounds. However, c-
fos and c-jun induction was transient in fetal skin while AP-1
expression persisted in scarring tissue [93].
Hox protein activity is essential during embryogenesis,
andtheHoxgeneshavebeenimplicatedinlimbregeneration
[94, 95] .An u m b e ro fH o xg e n e sa r ee x p r e s s e di nb o t h
fetal and adult skin [96, 97], however, fetal wounds show
an increase in expression of a number of the Hox genes
d u r i n gf e t a ls c a r l e s sr e p a i r[ 98, 99].Though HoxB 13 was
downregulated in fetal scarless wounds [99] and in an adult
model, Hoxb13 knockout animals showed a more fetal-like
healing phenotype [100].
Gene expression in fetal ﬁbroblasts shows diﬀerence gene
expression compared to adult ﬁbroblasts in response to
TGF-β1 in a number of experimental models [101, 102].
Colwell et al. [102] using genomic microarray demonstrated
that fetal wounds have greater increased expression in the
fraction of genes immediately after injury. As time after
injury lengthened, adult wounds showed the fraction of
genes with increased expression increasing. By twenty four
hours after injury there were fewer genes with diﬀerential
expression between the fetus and adult, with the majority
having greater expression found in the adult wound [102].
Chen et al. [103] showed that there were ﬁfty three genes
(0.93%) diﬀerentially expressed between early gestational
skin and late gestational skin from rats; 27 genes were
upregulated including FGF8, follistatin, and 26 genes were
downregulated including beta-catenin in fetal skin when
compared to adult skin [103].
7. Apoptosis, Proliferation,and Migration
A number of studies suggest that fetal ﬁbroblasts proliferate
more rapidly than adult ﬁbroblasts [104]. Though othersISRN Dermatology 5
Table 2: Summary of diﬀerences identiﬁed in fetal wound healing.
Fetal wound healing
Inﬂammation
Reduced immune cells, less activated,
lower levels of cytokines, and growth
factors due to reduced immune cells
[5–9]
Decreased expression IL-6 and IL-8
[16, 17]
Low levels of COX-2 and PGE2 [25]
Appear refractory to exogenous PGE2
[27]
ECM
Higher expression of hyaluronic acid
[30, 31]
Increased CD44 (hyaluronic acid
receptor) [33]
Tenascin C earlier deposition [42, 43]
Increased expression of some subunits
integrins [45]
Fibronectin isoforms
Reduced decorin [46]
Increase ﬁbromodulin [49]
Collagen ratio remain unclear but fetal
wounds [51, 52]
Have reduced cross-linking but
increased expression DDR [57]
Increased levels of MMPs and
urokinase plasminogen activator
reduced TIMPs and PAI-1 [58, 59]
Wound closure
Myoﬁbroblasts quick but transitory
appearance [67, 68]
Close wounds by actin cable [61, 62]
Growth factors See Table 1
Cell-signalling
transcription and
gene expression
Diﬀerence in phosphorylation in some
intracellular signalling pathways
[88, 89]
Transient increase in AP-1 [93]
Hox gene expression diﬀer [98, 99]
Cell behaviour Increased cleaved caspase 7
Increased cleaved PARP [106]
suggest that there is no diﬀerence between fetal epidermal
proliferation and adult proliferation [105].
Apoptosis is an important process in wound healing
occurring in inﬂammatory cells, myoﬁbroblasts, and vas-
cular cells, for example. Studies have shown that scarless
healing shows no diﬀerence in total caspase 3 or any cleavage
ofcaspase3comparedtoscarringhealinginamurinemodel.
However, scarless healing showed an increase in cleaved
caspase7afterwoundingwhilescar-formingwoundsshowed
no increase. Further scarless healing showed increased levels
of cleaved PARP while scar-forming healing only showed a
small amount of cleaved PARP [106].
8. Problems inFetal Wound-HealingResearch
A number of animal models have been used to study fetal
wound healing in vivo [54, 67, 107]. In addition a number
of in vitro studies have used human fetal-derived cells [68,
88, 90]. The use of diﬀerent species in wound healing studies
can make direct comparisons either diﬃcult or impossible
with diﬀerent species demonstrating variations in a num-
ber of wound-healing processes. Further complications in
comparing fetal wound healing are in the wound itself with
some studies using incisional wounds, excisional wounds, or
even wounds created by burns. Interestingly the ability of
the fetus to heal excisional wounds with perfect regeneration
has been shown to be species dependent [54, 108]. Further
some fetal excisional wounds undergo contraction (sheep)
[108] while others show no contraction in closing excisional
wounds (rabbits and monkeys) [107, 108].
9. Conclusion
The precise mechanism of fetal regeneration remains unclear
with a number of diﬀerences identiﬁed between the fetal and
adult wound healing (Table 2). A number of potential anti-
scarring therapeutics have evolved from understanding fetal
regeneration though to date none have completely prevented
scar formation. Recent studies have further suggested a role
for fetal cells in diﬃcult-to-heal wounds [109] through their
promoting eﬀect on adhesion, proliferation, and migration
of existing cells.
Further work is required to understand how fetal cells
promote regeneration and wound healing and if this can
be promoted in adult wound repair. Work will also need
to study the role that stem cells play in both adult and
fetal wound repair. However, understanding fetal wound
healing and regeneration will impact adult repair in the
future and may lead to the reduction or even prevention in
the formation of scar tissue in a number of organs.
Abbreviations
AP-1: Activator protein 1
COX-2: Cyclooxygenase-2
ECM: Extra cellular matrix
EGF: Epidermal growth factor
HA: Hyaluronic acid
IL: Interleukin
MMP: Matrix metalloproteinase
PDGF: Platelet derived growth factor
PGE2: Prostaglandin 2
TGF-β: Transforming growth factor-beta.
References
[1] U. Rowlatt, “Intrauterine wound healing in a 20 week human
fetus,” Virchows Archiv, vol. 381, no. 3, pp. 353–361, 1979.
[ 2 ]J .R .A r m s t r o n ga n dM .W .J .F e r g u s o n ,“ O n t o g e n yo ft h e
skin and the transition from scar-free to scarring phenotype
during wound healing in the pouch young of a marsupial,
Monodelphis domestica,” Developmental Biology, vol. 169,
no. 1, pp. 242–260, 1995.
[3] H. P. Lorenz, M. T. Longaker, L. A. Perkocha, R. W. Jennings,
M. R. Harrison, and N. S. Adzick, “Scarless wound repair: a
human fetal skin model,” Development, vol. 114, no. 1, pp.
253–259, 1992.
[4] M.T .L o ngak e r ,D .J .W hitb y ,M.W .J .F e rguso n,H.P .L o r e nz,
M. R. Harrison, and N. S. Adzick, “Adult skin wounds in6 ISRN Dermatology
the fetal environment heal with scar formation,” Annals of
Surgery, vol. 219, no. 1, pp. 65–72, 1994.
[5] A. J. Cowin, M. P. Brosnan, T. M. Holmes, and M. W.
Ferguson, “Endogenous inﬂammatory response to dermal
wound healing in the fetal and adult mouse,” Developmental
Dynamics, vol. 212, no. 3, pp. 385–393, 1998.
[6] J. Hopkinson-Woolley, D. Hughes, S. Gordon, and P. Martin,
“Macrophage recruitment during limb development and
wound healing in the embryonic and foetal mouse,” Journal
of Cell Science, vol. 107, no. 5, pp. 1159–1167, 1994.
[7] B. C. Wulﬀ, A. E. Parent, M. A. Meleski, L. A. Dipietro,
M. E. Schrementi, and T. A. Wilgus, “Mast cells contribute
to scar formation during fetal wound healing,” Journal of
Investigative Dermatology, vol. 132, no. 2, pp. 458–465, 2012.
[8] A.J.Cowin,T.M.Holmes,P.Brosnan,andM.W.J.Ferguson,
“Expression of TGF-β and its receptors in murine fetal and
adult dermal wounds,” European Journal of Dermatology, vol.
11, no. 5, pp. 424–431, 2001.
[ 9 ] T .A .W i l g u s ,A .M .F e r r e i r a ,T .M .O b e ry s z y n ,V .K .B e r g d a l l ,
and L. A. DiPietro, “Regulation of scar formation by vascular
endothelial growth factor,” Laboratory Investigation, vol. 88,
no. 6, pp. 579–590, 2008.
[10] F. W. Frantz, D. A. Bettinger, J. H. Haynes et al., “Biology of
fetal repair: the presence of bacteria in fetal wounds induces
an adult-like healing response,” Journal of Pediatric Surgery,
vol. 28, no. 3, pp. 428–434, 1993.
[11] S. ¨ Ozt¨ urk, M. Deveci, M. Sengezer, and ¨ O. G¨ unhan, “Results
ofartiﬁcialinﬂammationinscarlessfoetalwoundhealing:an
experimental study in foetal lambs,” British Journal of Plastic
Surgery, vol. 54, no. 1, pp. 47–52, 2001.
[12] E. I. Egozi, A. M. Ferreira, A. L. Burns, R. L. Gamelli, and L.
A. DiPietro, “Mast cells modulate the inﬂammatory but not
the proliferative response in healing wounds,” Wound Repair
and Regeneration, vol. 11, no. 1, pp. 46–54, 2003.
[13] A. M. Szpaderska, E. I. Egozi, R. L. Gamelli, and L. A.
DiPietro,“Theeﬀect of thrombocytopenia on dermal wound
healing,” Journal of Investigative Dermatology, vol. 120, no. 6,
pp. 1130–1137, 2003.
[14] J. V. Dovi, L. K. He, and L. A. DiPietro, “Accelerated wound
closure in neutrophil-depleted mice,” Journal of Leukocyte
Biology, vol. 73, no. 4, pp. 448–455, 2003.
[15] P. Martin, D. D’Souza, J. Martin et al., “Wound healing in
the PU.1 null mouse—tissue repair is not dependent on
inﬂammatory cells,” Current Biology, vol. 13, no. 13, pp.
1122–1128, 2003.
[16] K. W. Liechty, T. M. Crombleholme, D. L. Cass, B. Martin,
and N. S. Adzick, “Diminished interleukin-8 (IL-8) produc-
tion in the fetal wound healing response,” Journal of Surgical
Research, vol. 77, no. 1, pp. 80–84, 1998.
[17] K. W. Liechty, N. S. Adzick, and T. M. Crombleholme,
“Diminished interleukin 6 (IL-6) production during scarless
human fetal wound repair,” Cytokine, vol. 12, no. 6, pp. 671–
676, 2000.
[ 1 8 ] R .A l a m ,D .K u m a r ,D .A n d e r s o n - W a l t e r s ,a n dP .A .
Forsythe,“Macrophageinﬂammatoryprotein-1αandmono-
cyte chemoattractant peptide- 1 elicit immediate and late
cutaneous reactions and activate murine mast cells in vivo,”
Journal of Immunology, vol. 152, no. 3, pp. 1298–1303, 1994.
[19] L. A. DiPietro, P. J. Polverini, S. M. Rahbe, and E. J. Kovacs,
“Modulation of JE/MCP-1 expression in dermal wound
repair,” American Journal of Pathology, vol. 146, no. 4, pp.
868–875, 1995.
[20] L.A.DiPietro,M.Burdick,Q.E.Low,S.L.Kunkel,andR.M.
Strieter,“Mip-1αasacriticalmacrophagechemoattractantin
murine wound repair,” Journal of Clinical Investigation, vol.
101, no. 8, pp. 1693–1698, 1998.
[ 2 1 ]S .J .F o r t u n a t o ,R .M e n o n ,K .F .S w a n ,a n dS .J .L o m b a r d i ,
“Interleukin-10 inhibition of interleukin-6 in human amnio-
chorionic membrane: transcriptional regulation,” American
JournalofObstetricsandGynecology,vol.175,no.4,pp.1057–
1065, 1996.
[22] S. J. Fortunato, R. Menon, and S. J. Lombardi, “The
eﬀect of transforming growth factor and interleukin-10 on
interleukin-8 release by human amniochorion may regulate
histologic chorioamnionitis,” American Journal of Obstetrics
and Gynecology, vol. 179, no. 3, pp. 794–799, 1998.
[ 2 3 ] K .W .L i e c h t y ,H .B .K i m ,N .S .A d z i c k ,a n dT .M .
Crombleholme,“Fetalwoundrepairresultsinscarformation
ininterleukin-10-deﬁcientmiceinasyngeneicmurinemodel
of scarless fetal wound repair,” Journal of Pediatric Surgery,
vol. 35, no. 6, pp. 866–873, 2000.
[24] W. H. Peranteau, L. Zhang, N. Muvarak et al., “IL-10 over-
expression decreases inﬂammatory mediators and promotes
regenerative healing in an adult model of scar formation,”
JournalofInvestigativeDermatology,vol.128,no.7,pp.1852–
1860, 2008.
[25] T. A. Wilgus, V. K. Bergdall, K. L. Tober et al., “The impact
of cyclooxygenase-2 mediated inﬂammation on scarless fetal
wound healing,” American Journal of Pathology, vol. 165, no.
3, pp. 753–761, 2004.
[26] T. A. Wilgus, Y. Vodovotz, E. Vittadini, E. A. Clubbs, and T.
M.Oberyszyn,“Reductionofscarformationinfull-thickness
wounds with topical celecoxib treatment,” Wound Repair and
Regeneration, vol. 11, no. 1, pp. 25–34, 2003.
[27] V. C. Sandulache, A. Parekh, H. S. Li-Korotky, J. E. Dohar,
and P. A. Hebda, “Prostaglandin E2 diﬀerentially modulates
human fetal and adult dermal ﬁbroblast migration and
contraction: implication for wound healing,” Wound Repair
and Regeneration, vol. 14, no. 5, pp. 633–643, 2006.
[28] A. Parekh, V. C. Sandulache, A. S. Lieb, J. E. Dohar, and P.
A. Hebda, “Diﬀerential regulation of free-ﬂoating collagen
gel contraction by human fetal and adult dermal ﬁbroblasts
in response to prostaglandin E2 mediated by an EP2/cAMP-
dependentmechanism,”WoundRepairandRegeneration,vol.
15, no. 3, pp. 390–398, 2007.
[29] G. S. Schultz and A. Wysocki, “Interactions between extra-
cellularmatrixandgrowthfactorsinwoundhealing,”Wound
Repair and Regeneration, vol. 17, no. 2, pp. 153–162, 2009.
[ 3 0 ]M .T .L o n g a k e r ,E .S .C h i u ,N .S .A d z i c k ,M .S t e r n ,M .R .
Harrison, and R. Stern, “Studies in fetal wound healing: V.
A prolonged presence of hyaluronic acid characterizes fetal
wound ﬂuid,” Annals of Surgery, vol. 213, no. 4, pp. 292–296,
1991.
[31] T. Sawai, N. Usui, K. Sando et al., “Hyaluronic acid of wound
ﬂuid in adult and fetal rabbits,” Journal of Pediatric Surgery,
vol. 32, no. 1, pp. 41–43, 1997.
[ 3 2 ]D .C .W e s t ,D .M .S h a w ,P .L o r e n z ,N .S .A d z i c k ,a n dM .T .
Longaker, “Fibrotic healing of adult and late gestation fetal
wounds correlates with increased hyaluronidase activity and
removalofhyaluronan,”InternationalJournalofBiochemistry
and Cell Biology, vol. 29, no. 1, pp. 201–210, 1997.
[33] S. M. Alaish, D. Yager, R. F. Diegelmann, I. K. Cohen, and
N. S. Adzick, “Biology of fetal wound healing: hyaluronate
receptor expression in fetal ﬁbroblasts,” Journal of Pediatric
Surgery, vol. 29, no. 8, pp. 1040–1043, 1994.
[ 3 4 ]M .H u ,E .E .S a b e l m a n ,Y .C a o ,J .C h a n g ,a n dV .R .H e n t z ,
“Three-dimensional hyaluronic acid grafts promote healing
and reduce scar formation in skin incision wounds,” JournalISRN Dermatology 7
of Biomedical Materials Research, vol. 67, no. 1, pp. 586–592,
2003.
[ 3 5 ] J .A .I o c o n o ,H .P .E h r l i c h ,K .A .K e e f e r ,a n dT .M .K r u m m e l ,
“Hyaluronan induces scarless repair in mouse limb organ
culture,” Journal of Pediatric Surgery, vol. 33, no. 4, pp. 564–
567, 1998.
[36] B. A. Mast, R. F. Diegelmann, T. M. Krummel, and I. K.
Cohen, “Hyaluronic acid modulates proliferation, collagen
and protein synthesis of cultured fetal ﬁbroblasts,” Matrix,
vol. 13, no. 6, pp. 441–446, 1993.
[37] B. P. Toole, T. N. Wight, and M. I. Tammi, “Hyaluronan-
cell interactions in cancer and vascular disease,” Journal of
Biological Chemistry, vol. 277, no. 7, pp. 4593–4596, 2002.
[38] R. S. Cotran, V. Kumar, and T. Collins, Pathologic Basis
of Disease, WB Saunders Company, Philadelphia, Pa, USA,
1999.
[39] J. E. Schwarzbauer, “Alternative splicing of ﬁbronectin: three
variants, three functions,” BioEssays, vol. 13, no. 10, pp. 527–
533, 1991.
[40] F. Pagani, L. Zagato, C. Vergani, G. Casari, A. Sidoli, and
F. E. Baralle, “Tissue-speciﬁc splicing pattern of ﬁbronectin
messenger RNA precursor during development and aging in
rat,” J o u r n a lo fC e l lB i o l o g y , vol. 113, no. 5, pp. 1223–1229,
1991.
[41] A. F. Muro, A. K. Chauhan, S. Gajovic et al., “Regulated
splicing of the ﬁbronectin EDA exon is essential for proper
skin wound healing and normal lifespan,” Journal of Cell
Biology, vol. 162, no. 1, pp. 149–160, 2003.
[42] D. J. Whitby and M. W. J. Ferguson, “The extracellular
matrix of lip wounds in fetal, neonatal and adult mice,”
Development, vol. 112, no. 2, pp. 651–668, 1991.
[43] D. J. Whitby, M. T. Longaker, M. R. Harrison, N. S. Adzick,
and M. W. J. Ferguson, “Rapid epithelialisation of fetal
wounds is associated with the early deposition of tenascin,”
Journal of Cell Science, vol. 99, no. 3, pp. 583–586, 1991.
[ 4 4 ]M .T .L o n g a k e r ,D .J .W h i t b y ,M .W .J .F e r g u s o ne ta l . ,
“Studies in fetal wound healing: III. Early deposition of
ﬁbronectin distinguishes fetal from adult wound healing,”
Journal of Pediatric Surgery, vol. 24, no. 8, pp. 799–805, 1989.
[45] D. L. Cass, K. M. Bullard, K. G. Sylvester et al., “Epidermal
integrin expression is upregulated rapidly in human fetal
wound repair,” Journal of Pediatric Surgery,v o l .3 3 ,n o .2 ,p p .
312–316, 1998.
[46] S. R. Beanes, C. Dang, C. Soo et al., “Down-regulation
of decorin, a transforming growth factor-beta modulator,
is associated with scarless fetal wound healing,” Journal of
Pediatric Surgery, vol. 36, no. 11, pp. 1666–1671, 2001.
[47] P. G. Scott, C. M. Dodd, A. Ghahary, Y. J. Shen, and
E. E. Tredget, “Fibroblasts from post-burn hypertrophic
scar tissue synthesize less decorin than normal dermal
ﬁbroblasts,”ClinicalScience,vol.94,no.5,pp.541–547,1998.
[48] K.Sayani,C.M.Dodd,B.Nedelecetal.,“Delayedappearance
of decorin in healing burn scars,” Histopathology, vol. 36, no.
3, pp. 262–272, 2000.
[49] C. Soo, F. Y. Hu, X. Zhang et al., “Diﬀerential expression of
ﬁbromodulin, a transforming growth factor-β modulator, in
fetal skin development and scarless repair,” American Journal
of Pathology, vol. 157, no. 2, pp. 423–433, 2000.
[50] Z. Zhang, T. M. Garron, X. J. Li et al., “Recombinant human
decorin inhibits TGF-β1-induced contraction of collagen
lattice by hypertrophic scar ﬁbroblasts,” Burns, vol. 35, no.
4, pp. 527–537, 2009.
[51] K. R. Knight, D. A. Lepore, R. S. C. Horne et al., “Collagen
content of uninjured skin and scar tissue in foetal and adult
sheep,” International Journal of Experimental Pathology, vol.
74, no. 6, pp. 583–591, 1993.
[52] H. N. Lovvorn, D. T. Cheung, M. E. Nimni, N. Perelman,
J. M. Estes, and N. S. Adzick, “Relative distribution and
crosslinking of collagen distinguish fetal from adult sheep
wound repair,” Journal of Pediatric Surgery,v o l .3 4 ,n o .1 ,p p .
218–223, 1999.
[ 5 3 ]J .R .M e r k e l ,B .R .D i P a o l o ,G .G .H a l l o c k ,a n dD .C .
Rice, “Type I and Type III collagen content of healing
wounds in fetal and adult rats,” Proceedings of the Society for
Experimental Biology and Medicine, vol. 187, no. 4, pp. 493–
497, 1988.
[54] S. R. Goldberg, R. P. McKinstry, V. Sykes, and D. A. Lanning,
“Rapid closure of midgestational excisional wounds in a
fetal mouse model is associated with altered transforming
growth factor-β isoform and receptor expression,” Journal of
Pediatric Surgery, vol. 42, no. 6, pp. 966–973, 2007.
[55] R. Carter, K. Jain, V. Sykes, and D. Lanning, “Diﬀerential
expression of procollagen genes between mid- and late-
gestational fetal ﬁbroblasts,” Journal of Surgical Research, vol.
156, no. 1, pp. 90–94, 2009.
[56] A. S. Colwell, T. M. Krummel, M. T. Longaker, and H. P.
Lorenz, “Early-gestation fetal scarless wounds have less lysyl
oxidase expression,” Plastic and Reconstructive Surgery, vol.
118, no. 5, pp. 1125–1129, 2006.
[57] G.S.Chin,S.Lee,M.Hsuetal.,“Discoidindomainreceptors
andtheirligand,collagen,aretemporallyregulatedinfetalrat
ﬁbroblasts in vitro,” Plastic and Reconstructive Surgery, vol.
107, no. 3, pp. 769–776, 2001.
[58] E. Y. Huang, H. Wu, E. R. Island et al., “Diﬀerential
expression of urokinase-type plasminogen activator and
plasminogen activator inhibitor-1 in early and late gesta-
tional mouse skin and skin wounds,” Wound Repair and
Regeneration, vol. 10, no. 6, pp. 387–396, 2002.
[59] Z. M. Peled, E. D. Phelps, D. L. Updike et al., “Matrix
metalloproteinases and the ontogeny of scarless repair:
the other side of the wound healing balance,” Plastic and
Reconstructive Surgery, vol. 110, no. 3, pp. 801–811, 2002.
[60] C.M.Dang,S.R.Beanes,C.Sooetal.,“Decreasedexpression
of ﬁbroblast and keratinocyte growth factor isoforms and
receptors during scarless repair,” Plastic and Reconstructive
Surgery, vol. 111, no. 6, pp. 1969–1979, 2003.
[61] P. Martin and J. Lewis, “Actin cables and epidermal move-
ment in embryonic wound healing,” Nature, vol. 360, no.
6400, pp. 179–183, 1992.
[62] J. Brock, K. Midwinter, J. Lewis, and P. Martin, “Healing
of incisional wounds in the embryonic chick wing bud:
characterization of the actin purse-string and demonstration
of a requirement for Rho activation,” Journal of Cell Biology,
vol. 135, no. 4, pp. 1097–1107, 1996.
[63] A. J. Cowin, N. Hatzirodos, J. T. Teusner, and D. A. Belford,
“Diﬀerential eﬀect of wounding on actin and its associated
proteins, paxillin and gelsolin, in fetal skin explants,” Journal
of Investigative Dermatology, vol. 120, no. 6, pp. 1118–1129,
2003.
[64] S. Nodder and P. Martin, “Wound healing in embryos: a
review,” Anatomy and Embryology, vol. 195, no. 3, pp. 215–
228, 1997.
[65] J. McCluskey and P. Martin, “Analysis of the tissue move-
ments of embryonic wound healing—DiI studies in the limb
bud stage mouse embryo,” Developmental Biology, vol. 170,
no. 1, pp. 102–114, 1995.
[66] J. M. Estes, J. S. Vande Berg, N. S. Adzick, T. E.
MacGillivray, A. Desmouliere, and G. Gabbiani, “Phenotypic8 ISRN Dermatology
and functional features of myoﬁbroblasts in sheep fetal
wounds,” Diﬀerentiation, vol. 56, no. 3, pp. 173–181, 1994.
[67] D. L. Cass, K. G. Sylvester, E. Y. Yang, T. M. Crombleholme,
and N. S. Adzick, “Myoﬁbroblast persistence in fetal sheep
wounds is associated with scar formation,” Journal of Pedi-
atric Surgery, vol. 32, no. 7, pp. 1017–1022, 1997.
[ 6 8 ]K .J .R o l f e ,J .R i c h a r d s o n ,C .V i g o r ,L .M .I r v i n e ,A .O .
Grobbelaar, and C. Linge, “A role for TGF-β1-induced
cellular responses during wound healing of the non-scarring
early human fetus?” Journal of Investigative Dermatology, vol.
127, no. 11, pp. 2656–2667, 2007.
[69] C. Soo, S. R. Beanes, F. Y. Hu et al., “Ontogenetic transition
in fetal wound transforming growth factor-β regulation
correlates with collagen organization,” American Journal of
Pathology, vol. 163, no. 6, pp. 2459–2476, 2003.
[70] P. Martin, M. C. Dickson, F. A. Millan, and R. J. Akhurst,
“Rapid induction and clearance of TGFβ1 is an early
response to wounding in the mouse embryo,” Developmental
Genetics, vol. 14, no. 3, pp. 225–238, 1993.
[71] J. H. Levine, H. L. Moses, L. I. Gold, and L. B. Nanney, “Spa-
tial and temporal patterns of immunoreactive transforming
growth factor β1, β2, and β3 during excisiona wound repair,”
American Journal of Pathology, vol. 143, no. 2, pp. 368–380,
1993.
[72] M. Shah, D. M. Foreman, and M. W. J. Ferguson, “Control
of scarring in adult wounds by neutralising antibody to
transforminggrowthfactorβ,” TheLancet,vol.339,no.8787,
pp. 213–214, 1992.
[ 7 3 ] M .S h a h ,D .M .F o r e m a n ,a n dM .W .J .F e r g u s o n ,“ N e u t r a l i s -
ingantibodytoTGF-β1,2reducescutaneousscarringinadult
rodents,” J o u r n a lo fC e l lS c i e n c e , vol. 107, no. 5, pp. 1137–
1157, 1994.
[ 7 4 ]M .S h a h ,D .M .F o r e m a n ,a n dM .W .J .F e r g u s o n ,“ N e u t r a l i -
sationofTGF-β1andT GF -β2orexogenousadditionofTGF-
β3 to cutaneous rat wounds reduces scarring,” Journal of Cell
Science, vol. 108, no. 3, pp. 985–1002, 1995.
[75] M. W. Ferguson, J. Duncan, J. Bond et al., “Prophylac-
tic administration of avotermin for improvement of skin
scarring: three double-blind, placebo-controlled, phase I/II
studies,” The Lancet, vol. 373, no. 9671, pp. 1264–1274, 2009.
[76] L. Wu, A. Siddiqui, D. E. Morris, D. A. Cox, S. I. Roth, and T.
A. Mustoe, “Transforming growth factor β3( T G F β3) accel-
erates wound healing without alteration of scar prominence:
histologicandcompetitivereverse-transcription-polymerase
chainreactionstudies,”Archives of Surgery,vol.132,no.7,pp.
753–760, 1997.
[77] W. Chen, X. Fu, S. Ge et al., “Ontogeny of expression of
transforming growth factor-β and its receptors and their
possible relationship with scarless healing in human fetal
skin,” Wound Repair and Regeneration, vol. 13, no. 1, pp. 68–
75, 2005.
[78] Z.M.P eled,S.J .Rhee,M.Hsu,J .Chang,T .M.Krummel,and
M. T. Longaker, “The ontogeny of scarless healing II: EGF
and PDGF-B gene expression in fetal rat skin and ﬁbroblasts
asafunctionofgestationalage,” AnnalsofPlasticSurgery,vol.
47, no. 4, pp. 417–424, 2001.
[79] J. H. Haynes, D. E. Johnson, B. A. Mast et al., “Platelet-
derived growth factor induces fetal wound ﬁbrosis,” Journal
of Pediatric Surgery, vol. 29, no. 11, pp. 1405–1408, 1994.
[80] D. M. Ornitz and N. Itoh, “Fibroblast growth factors,”
Genome Biology, vol. 2, no. 3, article 3005, 2001.
[81] W. Chen, X. B. Fu, S. L. Ge, T. Z. Sun, and Z. Y. Sheng,
“Ontogeny of expression of basic ﬁbroblast growth factor
and its receptors in human fetal skin,” Chinese Journal of
Traumatology, vol. 8, no. 6, pp. 332–338, 2005.
[82] S. Ihara, Y. Motobayashi, E. Nagao, and A. Kistler, “Onto-
genetic transition of wound healing pattern in rat skin
occurring at the fetal stage,” Development, vol. 110, no. 3, pp.
671–680, 1990.
[83] A. S. Colwell, S. R. Beanes, C. Soo et al., “Increased angio-
genesis and expression of vascular endothelial growth factor
duringscarlessrepair,”PlasticandReconstructiveSurgery,vol.
115, no. 1, pp. 204–212, 2005.
[84] J. I. Jones and D. R. Clemmons, “Insulin-like growth factors
and their binding proteins: biological actions,” Endocrine
Reviews, vol. 16, no. 1, pp. 3–34, 1995.
[85] S. Beckert, S. Haack, H. Hierlemann et al., “Stimulation
of steroid-suppressed cutaneous healing by repeated topical
application of IGF-I: diﬀerent mechanisms of action based
upon the mode of IGF-I delivery,” Journal of Surgical
Research, vol. 139, no. 2, pp. 217–221, 2007.
[ 8 6 ]T .T .P h a n ,I .J .L i m ,B .H .B a ye ta l . ,“ R o l eo fI G Fs y s t e m
of mitogens in the induction of ﬁbroblast proliferation by
keloid-derived keratinocytes in vitro,” American Journal of
Physiology, vol. 284, no. 4, pp. C860–C869, 2003.
[87] A.Ghahary,Y.J.Shen,R.Wang,P.G.Scott,andE.E.Tredget,
“Expression and localization of insulin-like growth factor-1
innormalandpost-burnhypertrophicscartissueinhuman,”
Molecular and Cellular Biochemistry, vol. 183, no. 1-2, pp. 1–
9, 1998.
[ 8 8 ]K .J .R o l f e ,A .D .C a m b r e y ,J .R i c h a r d s o n ,L .M .I r v i n e ,A .
O. Grobbelaar, and C. Linge, “Dermal ﬁbroblasts derived
from fetal and postnatal humans exhibit distinct responses
to insulin like growth factors,” BMC Developmental Biology,
vol. 7, article 124, 2007.
[89] G. S. Chin, W. J. H. Kim, T. Y. Lee et al., “Diﬀerential
expression of receptor tyrosine kinases and Shc in fetal and
adult rat ﬁbroblasts: toward deﬁning scarless versus scarring
ﬁbroblast phenotypes,” Plastic and Reconstructive Surgery,
vol. 105, no. 3, pp. 972–979, 2000.
[90] H. Pratsinis, C. C. Giannouli, I. Zervolea, S. Psarras, D.
Stathakos, and D. Kletsas, “Diﬀerential proliferative response
of fetal and adult human skin ﬁbroblasts to transforming
growthfactor-β,” WoundRepairandRegeneration,vol.12,no.
3, pp. 374–383, 2004.
[91] A. S. Colwell, T. M. Krummel, M. T. Longaker, and H.
P. Lorenz, “Fetal and adult ﬁbroblasts have similar TGF-β-
mediated, Smad-dependent signaling pathways,” Plastic and
Reconstructive Surgery, vol. 117, no. 7, pp. 2277–2283, 2006.
[92] P. Martin and C. D. Nobes, “An early molecular component
of the wound healing response in rat embryos—induction
of c-fos protein in cell at the epidermal wound margin,”
MechanismsofDevelopment,vol.38,no.3,pp.209–216,1992.
[93] S. Gangnuss, A. J. Cowin, I. S. Daehn et al., “Regulation of
MAPK activation, AP-1 transcription factor expression and
keratinocytediﬀerentiationinwoundedfetalskin,”Journalof
Investigative Dermatology, vol. 122, no. 3, pp. 791–804, 2004.
[94] J. P. Brockes, “Amphibian limb regeneration: rebuilding a
complex structure,” Science, vol. 276, no. 5309, pp. 81–87,
1997.
[95] D. M. Gardiner, M. A. Torok, L. M. Mullen, and S. V.
Bryant, “Evolution of vertebrate limbs: robust morphology
and ﬂexible development,” American Zoologist, vol. 38, no. 4,
pp. 659–671, 1998.
[ 9 6 ]E .J .S t e l n i c k i ,L .G .K o m u v e s ,A .O .K w o n ge ta l . ,“ H O X
homeobox genes exhibit spatial and temporal changes inISRN Dermatology 9
expression during human skin development,” Journal of
Investigative Dermatology, vol. 110, no. 2, pp. 110–115, 1998.
[97] L. G. K¨ om¨ u v e s ,E .M i c h a e l ,J .M .A r b e i te ta l . ,“ H O X B 4
homeodomain protein is expressed in developing epidermis
andskindisordersandmodulateskeratinocyteproliferation,”
Developmental Dynamics, vol. 224, no. 1, pp. 58–68, 2002.
[98] K. Jain, V. Sykes, T. Kordula, and D. Lanning, “Homeobox
genes Hoxd3 and Hoxd8 are diﬀerentially expressed in fetal
mouse excisional wounds,” Journal of Surgical Research, vol.
148, no. 1, pp. 45–48, 2008.
[99] E.J.Stelnicki,J.Arbeit,D.L.Cass,C.Saner,M.Harrison,and
C. Largman, “Modulation of the human homeobox genes
PRX-2 and HOXB13 in scarless fetal wounds,” Journal of
Investigative Dermatology, vol. 111, no. 1, pp. 57–63, 1998.
[100] J. A. Mack, S. R. Abramson, Y. Ben et al., “HOXB13 knockout
adult skin exhibits high levels of hyaluronan and enhanced
woundhealing,”TheFASEBJournal,vol.17,no.10,pp.1352–
1354, 2003.
[101] K. J. Rolfe, L. M. Irvine, A. O. Grobbelaar, and C. Linge,
“Diﬀerential gene expression in response to transforming
growth factor-β1 by fetal and postnatal dermal ﬁbroblasts,”
Wound Repair and Regeneration, vol. 15, no. 6, pp. 897–906,
2007.
[102] A. S. Colwell, M. T. Longaker, and H. P. Lorenz, “Identiﬁca-
tion of diﬀerentially regulated genes in fetal wounds during
regenerative repair,” Wound Repair and Regeneration, vol. 16,
no. 3, pp. 450–459, 2008.
[103] W. Chen, X. Fu, S. Ge et al., “Proﬁling of genes diﬀerentially
expressed in a rat of early and later gestational ages with
high-density oligonucleotide DNA array,” Wound Repair and
Regeneration, vol. 15, no. 1, pp. 147–155, 2007.
[104] M. R. Khorramizadeh, E. E. Tredget, C. Telasky, Q. Shen, and
A. Ghahary, “Aging diﬀerentially modulates the expression
of collagen and collagenase in dermal ﬁbroblasts,” Molecular
andCellularBiochemistry,vol.194,no.1-2,pp.99–108,1999.
[105] W. Gerstein, “Cell proliferation in human fetal epidermis,”
Journal of Investigative Dermatology, vol. 57, no. 4, pp. 262–
265, 1971.
[106] R. Carter, V. Sykes, and D. Lanning, “Scarless fetal mouse
wound healing may initiate apoptosis through caspase 7 and
cleavage of PARP,” Journal of Surgical Research, vol. 156, no.
1, pp. 74–79, 2009.
[107] D.Sopher,“Astudyofwoundhealinginthefetaltissuesofthe
cynomolgus monkey,” Laboratory Animal Handbooks, vol. 6,
pp. 327–335, 1975.
[108] J. D. Burrington, “Wound healing in the fetal lamb,” Journal
of Pediatric Surgery, vol. 6, no. 5, pp. 523–528, 1971.
[109] J. Hohlfeld, A. De Buys Roessingh, N. Hirt-Burri et al.,
“Tissueengineeredfetalskinconstructsforpaediatricburns,”
The Lancet, vol. 366, no. 9488, pp. 840–842, 2005.